Patients with end-stage renal disease now have the option of home-based therapy using Amia, an automated peritoneal dialysis system with two-way remote connectivity from Baxter International Inc., which received FDA 510(k) clearance in October.
Peritoneal dialysis is a self-administered therapy that can be managed at home. An automated system like Amia allows treatment at...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?